Rio de Janeiro, 22 October 2019. The SPbSRIVS delegation headed by its director Viktor Trukhin took part in the 20th General Meeting of the Developing Countries Vaccine Manufacturers Network (DCVMN). Within the framework of this visit, a meeting was held between the directors of SPbSRIVS and PAHO at which the parties discussed the prospects for
Tagged under: ,
The Director of PAHO, Dr. Carissa F. Etienne, has launched in Brazil the 17th edition of Vaccination Week in the Americas, under the theme “Protect your community. Do your part”- Vaccination Week in numbers: At least 20 countries plan to vaccinate more than 2.25 million children and adults against measles (Anguilla, Bahamas, Barbados, Belize, British Virgin
Tagged under: ,
As part of the activities organized by the BIONICA project, which is coordinated by the vaccine plant MECHNIKOV and the National Autonomous University of Nicaragua (UNAN-Managua), from October 26 to November 2, the BIONICA camp was held at the UNAN-León. In that camp, Pharmaceutical Chemistry students of both universities shared their knowledge and experiences in
April, 11, Latin American institute of biotechnology MECHNIKOV received honored guests from the Ministry of Health of Russia, Nicaraguan Institute of the Social Security (INSS), Federal medical-biological agency of Russia, CECMED and WHO/PAHO, who united in Managua to participate in Russian-Nicaraguan Technical Advisory Committee. This time meeting of the Technical Committee was highlighted by the
Director of PAHO Doc. Carissa Etienne visited Institute of vaccines and serums in Saint Petersburg (SPbSRIVS) within the framework of cooperation between Pan American Health Organization and Federal Medico-Biological Agency of Russia (FMBA), which along with other institutions includes SPbSRIVS. Doctor Etienne arrived to Russia to be acquainted with the latest achievements of Russian public
At the information session for suppliers of vaccines and other medications to Latin America through special-purpose PAHO funds, representatives of the world’s leading pharmaceutical companies discussed the results of their activities over the past years and outlined plans for the future. For the first time, a representative of the Russian vaccine supplier, SPbSRIVS of the
Tagged under: , , , ,
  This Wednesday, February 3, the St. Petersburg Research Institute of Vaccines and Serums received the official Nicaraguan delegation led by the President of the Nicaraguan Social Insurance Institution (NSII), Dr. Roberto Lopez. Nicaraguan experts discussed with their Russian counterparts further steps to bring Russian-made vaccines, in particular influenza vaccines, and their synthesis technologies to
On February 18-20, a tripartite meeting was held by the representatives of Russia, Nicaragua, and the leadership of PAHO/WHO in Managua, Nicaragua. As a result of the meeting, a memorandum and an agreement of intent were signed. SPbSRIVS influenza vaccine and tuberculin, as well as its production facility in Krasnoye Selo will be registered in

GMP certificate issued to SPbSRIVS

On February 9, 2016, the GMP certificate was officially handed over to the Director of SPbSRIVS Mr. Victor Trukhin at the Third Technical Committee “Transfer of the influenza vaccine technology for the establishment of a joint Russian-Nicaraguan immunobiological plant” held in Managua, Nicaragua. The ceremony was held with support from PAHO office in Nicaragua, the